Asia Pacific home healthcare device and equipment market will grow by 9.0% annually with a total addressable market cap of $133.0 billion over 2021-2030 owing to the aging population worldwide, the prevalence of infectious diseases as well as the increasing prevalence of chronic diseases, technological innovation, and penetration of healthcare insurance. Highlighted with 42 tables and 57 figures, this 135-page report “Asia Pacific Home Healthcare Device and Equipment Market 2020-2030 b...
Global small molecule active pharmaceutical ingredient (API) market will reach $266.2 billion by 2027, growing by 7.3% annually over 2020-2027 owing to increasing incidences of diseases, development of companies engaged in the manufacturing of small molecule APIs, the increasing technological developments in manufacturing sector, and surge in healthcare expenditure amid COVID-19 pandemic. Highlighted with 85 tables and 85 figures, this 165-page report “Global Small Molecule API Market ...
North America small molecule active pharmaceutical ingredient (API) market is expected to grow by 5.7% annually in the forecast period and reach $90.22 billion by 2027 owing to increasing incidences of diseases, development of companies engaged in the manufacturing of small molecule APIs, the increasing technological developments in manufacturing sector, and surge in healthcare expenditure amid COVID-19 pandemic. Highlighted with 26 tables and 49 figures, this 107-page report “North Am...
Europe small molecule active pharmaceutical ingredient (API) market accounted for $38.35 billion in 2020 and will grow by 7.7% annually over 2020-2027 owing to increasing incidences of diseases, development of companies engaged in the manufacturing of small molecule APIs, the increasing technological developments in manufacturing sector, and surge in healthcare expenditure amid COVID-19 pandemic. Highlighted with 36 tables and 53 figures, this 113-page report “Europe Small Molecule API...
Asia Pacific small molecule active pharmaceutical ingredient (API) market will grow by 9.2% annually with a total addressable market cap of $537.3 billion over 2021-2027 owing to increasing incidences of diseases, development of companies engaged in the manufacturing of small molecule APIs, the increasing technological developments in manufacturing sector, and surge in healthcare expenditure amid COVID-19 pandemic. Highlighted with 33 tables and 52 figures, this 112-page report “Asia P...
Global pharmaceutical manufacturing industry will reach $673.6 billion by 2027, growing by 12.5% annually over 2020-2027 driven by increased drug approvals, increasing prevalence of chronic ailments, growing geriatric population, high investment in research and development, and increasing per capita healthcare expenditure amid the COVID-19 pandemic. Highlighted with 85 tables and 96 figures, this 185-page report “Global Pharmaceutical Manufacturing Industry 2020-2027 by Formulation, Rou...
North America pharmaceutical manufacturing industry is expected to grow by 11.0% annually in the forecast period and reach $241.76 billion by 2027 driven by increased drug approvals, increasing prevalence of chronic ailments, growing geriatric population, high investment in research and development, and increasing per capita healthcare expenditure amid the COVID-19 pandemic. Highlighted with 26 tables and 60 figures, this 125-page report “North America Pharmaceutical Manufacturing Indus...
Europe pharmaceutical manufacturing industry accounted for $84.31 billion in 2020 and will grow by 12.9% annually over 2020-2030 driven by increased drug approvals, increasing prevalence of chronic ailments, growing geriatric population, high investment in research and development, and increasing per capita healthcare expenditure amid the COVID-19 pandemic. Highlighted with 36 tables and 64 figures, this 131-page report “Europe Pharmaceutical Manufacturing Industry 2020-2027 by Formulat...
Asia Pacific pharmaceutical manufacturing industry will grow by 14.8% annually with a total addressable market cap of $1,034.6 billion over 2021-2027 driven by increased drug approvals, increasing prevalence of chronic ailments, growing geriatric population, high investment in research and development, and increasing per capita healthcare expenditure amid the COVID-19 pandemic. Highlighted with 33 tables and 63 figures, this 130-page report “Asia Pacific Pharmaceutical Manufacturing Ind...
ASEAN pharmaceutical manufacturing industry will grow by 12.8% annually with a total addressable market cap of $148.3 billion over 2021-2027 driven by increasing prevalence of chronic ailments, growing geriatric population, high investment in research and development, and increasing per capita healthcare expenditure amid the COVID-19 pandemic. Highlighted with 25 tables and 39 figures, this 66-page report “ASEAN Pharmaceutical Manufacturing Market 2017-2027 by Formulation and Country: T...
